Vic Mensa Pays It Forward

Victor Kwesi Mensah—known professionally as Vic Mensa—is a man who fully embodies what it means to be an artist. He’s got the drive, the spirituality, the sound, and most of all, the confidence. But how does one attain the knowhow to be a successful artist, let alone be successful at anything?

The answer lies in a strong support system. Mensa has been surrounded by supportive people for most of his life, dating back to high school where his band Kids These Days was drawing the eye of major record labels and prominent record producers. It was during these formative years that Mensa realized he had talent, honed his craft, and was propelled by the love and support of family and friends to tap into his potential. That potential is now culminating with a second full-length album, a record that’s sonically rooted in hip-hop, jazz, and African music.

When we connect over Zoom, Mensa reveals more about his upbringing and how it helped shape the man he is today. He lays bare his longtime relationship with cannabis, morphing from a teen trying to sell pot he didn’t possess, to owning a socially conscious weed company—93 Boyz—Chicago’s first Black-owned cannabis brand, and how the intersection of weed, fashion, art, and music provided the bedrock for his ascension from a Chicago fresh kid to an inspiring artist kids can look up to.

High Times Magazine: Growing up in Chicago, did you always know you wanted to pursue music?

Vic Mensa: I was a skateboarder first from age 6. By the time I was in third or fourth grade, I was starting to choose my own music, and was more interested in rock and roll. So I started playing guitar when I was 10. After that, I started writing graffiti, and that was really my introduction to hip-hop.

I was climbing 15-story fire escapes, painting rooftops and jumping on train tracks to paint trains before I was technically in my teens. Zoo York was a big influence of mine and there was a Zoo York video—I think they called it the Zoo York Mixtape—that had some KRS-One in there, which was probably the first hip-hop that really resonated with me.

Did you have a particular style of graffiti art and/or skateboarding, and did that style evolve into what you were doing early on with music?

I think all of those things are intertwined because they’re street culture and counterculture. As far as a particular style of graffiti art, in Chicago, we have a lot of styles but I think we’re most known for straight letters, and I was influenced primarily by the Chicago graffiti legends. Straight, block letters, a kind of straight letter tag style. But I was also a student of the game from my earliest days. I was studying Los Angeles graffiti crews like MSK and New York guys like SKUF and Cope—all the OGs.

When I started to release and promote music, I was already familiar with traveling across the city promoting my name [through graffiti], even though at first it wasn’t my real name. I’d do my own wheatpaste posters and shit like that when I was in high school. I mean, I’ll still do a wheatpaste poster to this day, don’t get it fucked up, but off top, I’d definitely be out on a street corner with the bucket and the posters, treating it like graffiti. Because in a way, graffiti is street marketing. A lot of the people that do street marketing for record labels are graffiti guys. So graffiti and skateboarding are my two primary stylistic inspirations.

Photo by Gabe Oviawe

So you’re immersed in the graffiti world. Was there a moment when music suddenly became the primary focus?

Probably around freshman year of high school when I started to record. Just receiving positive feedback and reinforcement from people around me—not everybody, obviously, but from some people that I respected—did a lot for me. I recognized that I had a particular talent for writing rhymes, but you know man, honestly, I think one of the reasons why I focus myself on doing so much for the youth is because in the dawn of my youth, I know how much those votes of confidence did for me.

Like my big brother Dare who I have tatted on my wrist and who I’ve written a bunch of songs about—may he rest in peace. He was older than me—near my age now when I was a kid—and he brought me into Jam Crew, which was the primary southside Black graffiti crew and took me under his wing. He was like, “This my shorty, he’s dope. He’s dope in general.” Nobody knew I could rap, but they were just showing me love, boosting my confidence, and giving me opportunity. As I found my own path in what I really wanted to do, I already had that network of older guys in the city who supported me and would let me rock stages when they’d have shows and stuff like that.

So your brother helped you see that you were dope in a particular way—just as a human—and then from that, you were able to grow into yourself musically from that sort of base.

One-hundred percent. Those same people who showed me love when I was a kid trying to dress cool and do graffiti and all of that shit—those same people when I picked up a mic or released music to this day still give me opportunities.

In Chicago, one of our primary forms of cultural currency and a hub of creativity came from the boutiques and sneaker stores. We had a shop called Leaders that’s still around that was incredibly impactful to all of our upbringings, a place called Sir & Madame, which is also still in existence, and a place called PHLI. All of those places were these centers of inspiration, creativity, sneaker culture, art, hip-hip, and graffiti all at once.

Some of the first guys I knew who were heavy with weed, who were cutting edge, having the best weed and the most knowledge and information—all played into our existence as fresh kids from Chicago. We’ve always been involved with art, we’ve always been involved with fashion, we’ve always been involved with music, and we’ve always been involved with weed.

How did your relationship with the plant start and how did it evolve as you evolved as a human?

My relationship with cannabis began when I was 11. I was just like any other kid living in the city, sneaking out of my mom’s basement to smoke in the middle of the night, before school, or after school. In those ways, I became very familiar with weed and trying to sell it. But the problem was, I didn’t have any weed to sell!

So I was trying to sell all types of shit. I was trying to sell blunt guts in a bag to the kids at the private school down the street. I remember the first time I tried to sell some weed I was in seventh grade and had a dime of Reggie. I tried to take it across the way to the high school in the area and tried to sell it to one of my friends. He was like, “Damn, man. You ain’t even got no mids?” I was like, “Man, this is all I got right now. You gonna buy it or not?”

As I got into high school, a lot of my big homies sold weed and I caught a couple plugs and became the guy with the specialty product. It was me and my boy Joey Purp—we had the best weed in the school and we’d pride ourselves on having cutting edge strains at the time. I really thought I was the man when I had Jack Frost, which was a Jack Herer cross strain. I’d be having the OG Kush, the Master Kush, some OG Master Kush. That was our thing, being at the cutting edge of our community as far as weed was concerned.

I used to go as far as bagging up my weed in Nike SB lace bags. For somebody I was trying to impress, I’d bag up an eighth of Jack Frost in the Nike SB lace bag and they’d be like, “Oh, this thing’s fresh.”

I honestly learned so much from selling weed. Selling weed was my first entrepreneurial pursuit. Before I was selling a mixtape or anything like that, I was selling weed. To make it to school on time, I had to get up and bag up mad early. Sometimes people would want to shop super late, so I’d need to stay awake. I had to be punctual—or as punctual as a weed man is—but I’m just a punctual person in general. In those ways, selling weed provided the building blocks for my understanding of work ethic, and through selling weed, I funded all of my first music projects, purchased all of my studio time, paid for all of my music videos—everything. Cannabis enabled me to be in the studio and to express myself.

Photo by Gabe Oviawe

When it got you into the studio, was there a moment or set of experiences where it became clear that music had taken over and was going to be your main path?

The moment when I sort of stopped everything else was when I got robbed, as a high schooler selling weed inevitably does. I was hustling serving guys who were way older than me—guys in their 20s who had newborn babies but were shopping with me buying quarters and halves daily—and I’m just a little ass kid. Eventually, I did get set up and robbed and lost a laptop with a bunch of important music on it. But around that same time, my father was really supportive of my music shit and was sometimes giving me money to go to the studio. So I just kind of fell back, you know?

It was the same way with graffiti. We kept getting arrested and eventually that was just in the way because music was starting to support itself. Everything else became ancillary—graffiti, hustling—things that were not my primary focus anymore—and I dove into music headfirst.

As you started to hit a certain level professionally, was there a “good omen” like in the Alchemist book that made you feel entrenched in music?

I was in a band in high school and we were performing at SXSW and different festivals courting all of the major record labels. In fairness, a lot of that was people reaching out to me, but I was loyal to the band. People loved the band as well, don’t get me wrong, but No I.D. reached out early on and was rocking with me so much that he was like, “I’ll check the band out.” The real life attrition was there, and this was the blog era, too, so we were getting love on all the blogs—2DopeBoyz, iLLRoots—and building relationships with all of those people. Even before music was paying anything, it was already real in high school and we were building a grassroots fanbase. We were selling out 1,500-person venues in Chicago when we were 16 and 17, so pretty quickly, the music became real.

I personally already had an understanding of grassroots marketing and communication from graffiti and hustling, so I’m selling tickets in the hallway the same way I’m selling dope, you know? Maybe at the same time. I’m putting up posters and stickers all over the city the same way I was just busting tags. On top of that, we were just making good music. The music became a clearly viable pathway pretty quickly.

Throughout your career, you’ve been outspoken about psychedelics and mental health. When did you start to understand the benefits of psychedelics and did they play a role in your success?

I got into psychedelics when I was 18 or 19. The first day I ever took shrooms I was sleeping on my manager-at-the-time’s couch and Chance [The Rapper] came over and he had a hook and a verse for a song that would become Cocoa Butter Kisses. I took the mushrooms, went into the other room, started writing my verse, and just caught a spirit. It was like, “Whoa, this is different.”

From there, I was taking mushrooms constantly in the making of that album called the INNANETAPE and [mushrooms] became a real part of my lifestyle. Throughout my life, plant medicine has been important to me and has played a big role in my different journeys as a human being. I chilled out on shrooms for a while after [INNANETAPE] because I had just overdone it.

The ways in which I’ve used mushrooms in recent years have been in a microdosing capacity and in a much more healing capacity. I started taking antidepressants when I was 15. I started seeing psychiatrists at that same age—therapists shortly after—and in the last 14 years, I’ve taken over 10 antidepressant medications. In that same time period, I’d probably had one year when they were effective, which is a dismal efficacy rate.

I’ve found that plant medicine has just been far more impactful to me in addressing my mental health than pharmaceuticals have, and I think the pharmaceutical industry is scared shitless about the potential for disruption that all of these different medicines present.

It’s like you start taking [pharmaceuticals] and you think that it’s helping because if you miss a couple of days you’re like, “Oh shit, I’m really bad, I’m suicidal now.” Then you remember you were never suicidal when you started taking the medication! The medicine is making me dependent on it. I was struggling when I first started taking it, but I wasn’t trying to kill myself. When you’re dealing with some of these plant medicines, you’re getting a more straight deal.

In the best moments, I think [plant medicine] can help move inhibition. Creativity is not of man in its purest form. It’s given to us from whatever you believe is above us. If it’s God or it’s Allah or the universe or the ancestors—at the end of the day—I believe we’re all just a vessel for a more powerful, divine energy. In the best moments of our creativity, we’re the most uninterrupted sacral. It’s like a radio, and [plant medicine] can help you pick up [the frequency]. They can help pick up the signal.

I’m learning more how to harness things as tools, but to train myself to be the primary influence. These days, I stray away from relying on being under the influence of anything other than myself. That doesn’t mean I won’t ever have external influences, but I work on my meditation a lot. Meditation has been the most powerful tool for me in addressing my mental health.

I’ve been meditating since I was 16, and in recent years, my meditation has become far more consistent and more extensive. I’ve learned more techniques, I’ve been on five-day silent meditation retreats, and I’ve studied different meditations from different places in the world. In terms of cannabis, some of its traditional uses were as a meditative tool. People think of Rastafarianism as a happy-go-lucky “by the beach, mon,” lackadaisical idea. In reality, those Rastas are vegan, deeply spiritual, deeply meditative, deeply revolutionary, and they meditate with the ganja. Meditation is my medicine above all.

If I haven’t meditated in a day, I find myself getting aggravated over little things I can’t control. Meditation is my first line of defense.

The paradox is that sometimes you’ll need a plant medicine experience to understand that you don’t need plant medicine to get to an elevated place.

There are breathing exercises and meditations you can do that will get you as high as any weed or psychedelic spirit medicine. One of my favorite things these days is to microdose mushrooms and complete an hour-and-15-minute-long meditation from a book by Dr. Joe Dispenza. I usually don’t do guided meditations because I like the practice of disciplining myself, but the meditation in this book Breaking The Habit of Being Yourself is so wicked that it’s like being on an astral plane. When I microdose, I’m taking non-psychoactive doses, which helps me tap into my internal power.

Photo by Gabe Oviawe

In January, you had an incident with psychedelics that made headlines. How did it go down?

I was headed to Ghana for about a month and I’d decided to get off my antidepressant medication. For the past few years, I’ve been dabbling with microdosing, but not really in the most consistent way. I had that experience that I mentioned previously where I had recently started taking a new antidepressant, took a few days off and started to feel suicidal. But I then realized I wasn’t suicidal when I’d started taking the medication, and decided to get off of it.

So I was off to Ghana and was going to quit the antidepressant cold turkey. I was going to get on a real microdosing regimen, not have a drink when I got there, and take this step for my mental health. I reached out to a couple different companies just to get the right microdose of shrooms and they sent me a bunch of shit. Pretty carelessly, I threw it all in my bag and took off.

I had a great experience there, no issues getting off of the antidepressants. All of the microdosing was cool and I just put all the shit back in the bag, wasn’t thinking too hard about it, and then I ended up going to jail.

In all honesty, what I had on me probably added up to an eighth of shrooms and a single tab of acid—which was an LSD microdose—so the entire bottle was one dose. It was a very miniscule amount of psychedelics in big packaging. But I was in such a cool place in my mind, had been meditating a ton, and was in such spiritual alignment that I wasn’t stressed.

I’ve been working with a lot of folks recently in the prison release space and was actually able to help a friend of mine come home 12 years early on a 25 year sentence in 2020. So at the end of the day, being involved in clemency processes and legal processes for bringing other guys home made being in jail for a couple days—especially with the perspective that I have of these friends who are living years of their life in prison—a miniscule experience.

My meditations also gave me a brilliant edge in there, to the point where I was just meditating the whole time to avoid thinking negatively. I’d come in front of the bail court and she was like, “Yeah, we’re going to move your court date to three months from now.” It’s those things that will make your mind want to freak out, but I was in a place of real alignment, so I wasn’t stressed and decided to see things as a blessing in the form of a lesson, and was like, “I’m going to get into the psychedelic game, too!”

Photo by Gabe Oviawe

At this point, the medical and health benefits are undeniable.

The actual, tangible, biochemical serotonin levels in your mind are boosted. It’s like the laws of this nation are proven time and time again to be ineffective at meeting the needs of the people. The people are sick, are in constant fear and danger of gun violence, are poorly fed nutritionally, and the laws of this nation are incapable of addressing any solution to those many needs. So sometimes, you gotta go to jail for some shit that’s stupid.

In May, I launched the first black-owned cannabis brand in Chicago, Illinois—93 Boyz. We’re in quite a few dispensaries and are rapidly expanding. We all know what the War on Drugs has done to Black and brown communities, but it still stands that our representation in the industry is miniscule. So we’re taking steps to change that.

Our brand is standing on high quality and cutting edge genetics in a market that doesn’t really have that yet. Also baked into our ethos is that a portion of all of our proceeds are going to community-driven efforts. And that’s what 93 Boyz is all about: Tastemaker weed mixed with socially-minded initiatives.

Our first project that we’re launching in August with the release of our full strain portfolio is a project called Books Before Bars. We’re putting over one-thousand books into Illinois jails and prisons. This is an idea I had from my own experience sending literature to people in prison and seeing how their entire life experience can be—and has been—shifted by reading the right books. If you can’t attain freedom yet in the physical, you can get it in the mental while you’re still in the cage.

vicmensa.com 

This interview has been edited for length and clarity. 

The post Vic Mensa Pays It Forward appeared first on High Times.

What Does Dr. Julian Somers Actually Believe?

What does Dr. Julian Somers actually believe? Dr. Julian Somers is a researcher and professor in the mental health and addiction field in British Columbia, Canada. He is currently a professor at Simon Fraser University and serves as the Research Director of the Mental Health and Addictions Research Program. In addition to his research, Julian has received numerous awards and recognitions for his contributions to the field of mental health, including the Canadian Institutes of Health Research (CIHR) Applied Public […]

The post What Does Dr. Julian Somers Actually Believe? appeared first on Cannabis | Weed | Marijuana | News.

Poilievre Misdiagnoses Opioid Crisis

Conservative Party leader Pierre Poilievre misdiagnoses the opioid crisis in the latest video, “Everything Feels Broken.” In the five-minute video, Poilievre uses a Vancouver tent city as his backdrop to make a case for the drug war. For a decade, British Columbia (among other Canadian cities) has provided a clean, safe supply of drugs for the addicted. He calls it a “failed experiment” brought in by “woke Liberal and NDP governments,” before saying he’ll end this policy and instead put […]

The post Poilievre Misdiagnoses Opioid Crisis appeared first on Cannabis | Weed | Marijuana | News.

Getting Gelly with It: How Gel Might Transform Cannabis Treatments

What if I told you that medicinal cannabis could take a new form soon? This upcoming gel might transform cannabis treatments. PreveCeutical, a pharmaceutical company based in Vancouver, recently acquired the rights to commercialize “Sol-Gel” technology. Sol-Gel, developed by a group of researchers at the University of Queensland in Australia, is basically a spray that […]

The post Getting Gelly with It: How Gel Might Transform Cannabis Treatments appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Pfizer Entering Cannabis Space Through $6.7 Billion All-Cash Acquisition

Pharmaceutical giant Pfizer Inc. is getting involved in the medical cannabis industry through the $6.7 billion, all-cash acquisition of Arena Pharmaceuticals, a California-based company specializing in autoimmune and cardiovascular treatments, who also has a cannabinoid medication currently in their pipeline.  

The two publicly traded companies confirmed the deal last week. As per the agreement, Pfizer will own all outstanding shares of Arena, which they purchased for a total of $100 per share. This marks their eighth major acquisition over the last 20 years.  

Like with most other beneficial compounds, big pharma is looking to take over cannabis too. Only, when pharma comes in, you get much less of the natural healing compounds and a whole lot of synthetics and derivatives. That said, now is the time to shop for products, while we still can. For more articles like this one, and for exclusive deals on flowers, vapes, edibles, and other legal products, remember to subscribe to The THC Weekly Newsletter for deals on legal cannabis products, as well as all the latest news and industry stories. Also save big on Delta 8Delta 9 THCDelta-10 THCTHCOTHCVTHCP & HHC products by checking out our “Best-of” lists!


Pfizer and their rise to fame 

Pfizer Inc. is a multinational, American-headquartered, pharmaceutical and biotech corporation based in Manhattan, New York City, NY. The company was founded by two German immigrants in 1849, Charles Pfizer and his cousin Charles F. Erhart.  

By the 1950s, Pfizer was now a global company with offices in Canada, Belgium, Brazil, Cuba, Mexico, Panama, Puerto Rico, and the United Kingdom, as well as many locations throughout the United States. In 1960, their major US research facility was moved from New York City to Groton, Connecticut.  

In 1980, Pfizer released its first billion-dollar product – Feldene (piroxicam), a prescription-only anti-inflammatory treatment. Their next major product to receive approval was Diflucan (fluconazole) in 1981, an oral medication used to treat several types of fungal infections including candidiasis, blastomycosis, coccidiodomycosis, cryptococcosis, histoplasmosis, dermatophytosis, and pityriasis versicolor. 

In 1989, Pfizer accidentally created one of their most popular medications, Viagra. Initially intended to treat high blood pressure and angina, early trials showed it was not effective for these conditions. It did, however, have an interesting side effect. Trial volunteers reported increased erections after taking the medicine. It was patented for this purpose and received approval from the FDA in March 1998. By the end of 1999, Pfizer had already made $1 billion off Viagra sales.  

Along with Viagra, Pfizer also released Zoloft around the same time. Zoloft is a highly controversial anti-depressant that has been the central focus of hundreds of lawsuits. At the heart of many cases was an increased risk of violent behavior, mania, aggression, and even suicidal tendencies; the exact conditions a medication like this is supposed to alleviate. These symptoms were common at the start of treatment or anytime the patients’ doses were changed.

Additional side effects of Zoloft include: agitation, hallucinations, fever, overactive reflexes, tremors; nausea, vomiting, loss of appetite, feeling unsteady, loss of coordination; trouble concentrating, memory problems, weakness, fainting, seizure, shallow breathing, or breathing that stops. 

COVID-19 Vaccine 

Despite their long list of existing – albeit sometimes questionable – medications and practices, it wasn’t until the start of this year that Pfizer truly became a household name in nearly every country on earth, following the development of their mRNA COVID-19 vaccine. As controversial as this vaccine may be, there is one thing that no one can deny – it’s a serious money maker.  

By June, the company had already made roughly $11.3 billion off the vaccine, based on their Q1 and Q1 reports. Now that the booster is available, Pfizer expects its Covid-19 vaccines to bring in roughly $33.5 billion in revenue by the end of 2021, which would make it one of their best-selling medications, ever.  

According to a review of 120,000 COVID-19 hospitalizations between June and September 2021, 15 percent are breakthrough cases, and that number is expected to rise significantly with the omicron variant. Some experts believe that soon, most Covid cases will be breakthroughs. A “breakthrough” case refers to new covid cases in vaccinated patients.  

Considering the short-lived efficiency of the vaccine, and the fact that pharmaceutical companies are pushing for boosters every six months, there’s certainly a lot of money to be made in the vaccine game, for those who were able to get a foot in early on.  

Who is Arena Pharmaceuticals? 

Arena Pharmaceuticals is a biotechnology company based San Diego, California and founded in 1997. Their main area of study, up until now, has been in the fields of autoimmune, cardiovascular, and gastrointestinal diseases and they’ve been working on different small molecule medicines for these conditions.

The cannabinoid medication they’re formulating is called Olorinab (APD371). It’s an oral medication that will function as a full agonist of the CB2 receptors. They are researching the effectiveness of this treatment against numerous different health conditions and symptoms, but they are focused primarily on visceral pain associated with gastrointestinal illness.  

In other, non-cannabinoid areas of the pipeline, Arena has been working on medications for the treatment of many different immuno-inflammatory diseases, heart conditions, gastroenterology, and dermatology. Currently, all their drugs are still in the development stage.  

About the $6.7 billion all-cash deal 

“The proposed acquisition of Arena complements our capabilities and expertise in Inflammation and Immunology, a Pfizer innovation engine developing potential therapies for patients with debilitating immuno-inflammatory diseases with a need for more effective treatment options,” stated Mike Gladstone, global president & general manager, Pfizer Inflammation and Immunology.  

“Utilizing Pfizer’s leading research and global development capabilities, we plan to accelerate the clinical development of etrasimod for patients with immuno-inflammatory diseases,” he added. Etrasimod is Arena’s prime future treatment option for immune-mediated inflammatory disease.  

President and CEO of Arena Pharmaceuticals, Amit D. Munshi, stated that they are “thrilled” to have been acquired by Pfizer, and remarked on “Arena’s potentially best in class S1P molecule and our contribution to addressing unmet needs in immune-mediated inflammatory diseases. Pfizer’s capabilities will accelerate our mission to deliver our important medicines to patients. We believe this transaction represents the best next step for both patients and shareholders.” 

Big Pharma Entering Cannabis Space 

As big of news as this is, it’s not the first example of a large pharmaceutical company getting involved in cannabis, and it certainly won’t be the last. Most recently, earlier this year, Jazz Pharmaceuticals purchased GW Pharmaceuticals, a cannabinoid drug company from the UK that developed Epidiolex, the first FDA-approved CBD medication. It has also earned approval in Japan and most of Europe. Epidiolex is used to treat two rare forms of childhood epilepsy, Lennox-Gastaut Syndrome and Dravet Syndrome.  

Back in 2018, Tilray, a major Canadian-based cannabis corporation, finalized a supply and distribution deal with Novartis AG, a Swiss multinational pharmaceutical company. Johnson & Johnson is also eyeing the industry, and has even allowed cannabis company Avicanna to utilize their 40,000-square-foot research facility, Innovation JLABS@Toronto. This type of setup can provide startups with flexible and stable labs to test products, without the “investor” actually taking a financial stake in the company.  

Final Thoughts 

The main takeaway here is that big pharma is very familiar with the benefits of cannabis, and once it’s federally legal, large pharmaceutical companies will be making major moves in the medical sector. With companies like this, it’s all about the money, and they’re just waiting for the right time to pull the plug. But keep in mind that the minute real THC (not synthetic) is used in a pharmaceutical drug, it can no longer be sold as a wellness supplement or recreational product. So if the day ever comes that pharmaceutical companies start using plant-extracted THC in their formulations, the industry as we know it will cease to exist.

Hello and welcome! Thanks for stopping by CBDtesters.co, your #1 web source for cannabis and psychedelics-related news, offering the most interesting stories of today. Join us frequently to stay on-top of the quickly-moving world of legal drugs and industrial hemp, and remember to check out The THC Weekly Newsletterto ensure you’re never late on getting a story.

Disclaimer: Hi, I’m a researcher and writer. I’m not a doctor, lawyer, or businessperson. All information in my articles is sourced and referenced, and all opinions stated are mine. I am not giving anyone advise, and though I am more than happy to discuss topics, should someone have a further question or concern, they should seek guidance from a relevant professional.

The post Pfizer Entering Cannabis Space Through $6.7 Billion All-Cash Acquisition appeared first on CBD Testers.

Jury Finds Pharmacy Chains Contributed to Ohio’s Opioid Crisis

A federal jury in Ohio on Tuesday found that pharmacy giants Walgreens, CVS and Walmart contributed to the opioid crisis in that state, a verdict that could serve as a bellwether for thousands of similar cases pending from coast to coast. The decision is the first verdict returned by a jury that holds a pharmacy retailer responsible for its role in the devastating epidemic of opioid overdoses that has plagued the United States for decades.

In the lawsuit, Lake and Trumbell Counties in northeastern Ohio maintained that the pharmacy retailers had recklessly distributed more than 100 million opioid pain pills in the counties, leading to addiction, death and a strain on public services. Between 2012 and 2016, more than 80 million prescriptions painkillers were dispensed in Trumbull County alone, or about 400 pills for every resident. During the same period, approximately 61 million opioid painkillers were dispensed in Lake County.

“For decades, pharmacy chains have watched as the pills flowing out of their doors cause harm and failed to take action as required by law,” a committee of attorneys representing local governments in federal opioid lawsuits said in a statement. “Instead, these companies responded by opening up more locations, flooding communities with pills, and facilitating the flow of opioids into an illegal, secondary market.”

Counties Say Pharmacies Created a Public Nuisance

Attorneys for the plaintiffs argued that the actions of the pharmacies amounted to a public nuisance that cost the counties about $1 billion each to address. Mark Lanier, an attorney representing the counties, said that the pharmacies failed to hire or train enough employees and implement systems to prevent suspicious orders from being filled.

“The law requires pharmacies to be diligent in dealing drugs,” Lanier said. “This case should be a wake-up call that failure will not be accepted.” 

“The jury sounded a bell that should be heard through all pharmacies in America,” he added.

The suit originally also named pharmacy retailers Rite-Aid and Giant Eagle as plaintiffs in the case. Rite-Aid settled in August and agreed to pay Trumbull County $1.5 million in damages, while a settlement amount with Lake County has not been released. Giant Eagle agreed to settle late last month, although terms of that agreement were not disclosed.

The case, which was decided by a 12-person jury after a six-week trial, was returned in one of about 3,000 federal opioid lawsuits being supervised by U.S. District Judge Dan Polster in Cleveland. Adam Zimmerman, who teaches mass litigation at Loyola Law School in Los Angeles, said that the verdict could prompt other pharmaceutical retailers to settle their pending cases.

“It’s the first opioid trial against these major household names,” Zimmerman told the New York Times. “They have been the least willing group of defendants to settle, so this verdict is at least a small sign to them that these cases won’t necessarily play out well in front of juries.”

Pharmacy Chains Will Appeal Verdict

All three retailers have indicated that they will appeal the jury’s verdict. Walmart said in a statement that the plaintiffs’ attorneys sued “in search of deep pockets while ignoring the real causes of the opioid crisis—such as pill mill doctors, illegal drugs, and regulators asleep at the switch—and they wrongly claimed pharmacists must second-guess doctors in a way the law never intended and many federal and state health regulators say interferes with the doctor-patient relationship.”

Walgreens spokesperson Fraser Engerman characterized the case as an unsustainable effort “to resolve the opioid crisis with an unprecedented expansion of public nuisance law,” adding that the company “never manufactured or marketed opioids nor did we distribute them to the ‘pill mills’ and internet pharmacies that fueled this crisis.”

“As plaintiffs’ own experts testified, many factors have contributed to the opioid abuse issue, and solving this problem will require involvement from all stakeholders in our health care system and all members of our community,” CVS spokesperson Mike DeAngelis said in a statement after the verdict was announced.

The retail pharmacies are not alone in their criticism of the verdict. Dr. Ryan Marino, an assistant professor of the Departments of Emergency Medicine and Psychiatry at Cleveland’s Case Western Reserve University School of Medicine, says that focusing on blaming the pharmaceutical industry, prescribers, and pharmacies ignores the role that bad policies have played in the opioid crisis.

“If retail pharmacies are declared responsible, I ask that we also hold policymakers responsible for their role in driving people to foreseeable death and failing to act to prevent disordered substance use or addiction by failing to provide access to safety in addition to basic things like housing, education, employment, and income, which are well known to prevent addiction in the first place,” Marino wrote in an email to High Times. “The same old approaches have not helped this problem, and in fact, seem to be only making it worse.”

Some drug manufacturers and distributors including Johnson & Johnson have also opted to settle cases brought against them for their alleged contributions to the opioid crisis, which has killed more than 500,000 Americans over the past twenty years. Kevin Roy, chief public policy officer at addiction solutions advocacy group Shatterproof, said that Tuesday’s verdict could prompt other pharmacies to consider a settlement.

“It’s a signal that the public, at least in select places, feels that there’s been exposure and needs to be remedied,” Roy said.

Roy noted, however, that the different courts hearing opioid cases have not been consistent in their judgments and that the details of public nuisance laws vary from state to state. Earlier this month, a California judge ruled in favor of drug manufacturers in a case brought by the city of Oakland and three counties. And in Oklahoma on November 9, the state Supreme Court overturned a 2019 verdict for $465 million against Johnson & Johnson.

“There’s been a variety of different decisions lately that should give us reason to be cautious about what this really means in the grand scheme,” Roy said.

Just how much Walgreens, CVS and Walmart will have to pay Trumbull and Lake Counties remains to be seen. The judge is expected to issue a decision on damages to be awarded in the case in the spring.

The post Jury Finds Pharmacy Chains Contributed to Ohio’s Opioid Crisis appeared first on High Times.

Breaking the stigma: Psychedelic Drugs

There are a lot of negative stigma surrounding psychedelic drugs. A large portion of the population and the government condemn these substances to be dangerous, addictive, and illegal. Although, that may be true when it comes to opiates or stimulants (such as heroin or cocaine). As they are, indeed, physiologically toxic and addictive. Psychedelics, on […]

The post Breaking the stigma: Psychedelic Drugs appeared first on Latest Cannabis News Today – Headlines, Videos & Stocks.

Tuesday, August 4, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Tuesday, August 4, 2020 | Curated by host Shea Gunther

// Cannabis, Lies, and Foreign Cash: A Mother and Daughter’s Journey Through the Underground Mask Trade (Pro Publica)

// Tight capital markets – worsened by COVID-19 – derail Schwazze’s cannabis acquisitions (Marijuana Business Daily)

// Black residents made up 97% of marijuana arrests in New York state capital (Leafly (AP))


These headlines are brought to you by Green Worx Consults, a company specializing in project management, workflow mapping and design, and Lean & 6 Sigma process. If you could use help making your business better at business, get in touch with Green Worx Consults.


// Analyzing Congress’s Latest Vote To Protect Legal Marijuana States From Federal Enforcement (Marijuana Moment)

// FDA approves GW Pharmaceuticals’ cannabis drug for new indication (Marijuana Business Daily)

// Massachusetts Senator Gives Wicked Chill Marijuana Response To Blunt-Smoking Constituent (Marijuana Moment)

// Major Cannabis Companies Shun Oklahoma (Fresh Toast)

// The pandemic is eating away at the illicit marijuana market (Politico)

// Louisiana Law Allowing Medical Marijuana For Any Debilitating Condition To Take Effect (Marijuana Moment)

// Recreational marijuana sales reached almost $61 million in July, setting a record for the third month in a row (Chicago Tribune)


Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: michael_swan/Flickr

Tuesday, April 7, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Tuesday, April 7, 2020 | Curated by host Shea Gunther

// Businesses That ‘Indirectly’ Work With Marijuana Industry Ineligible For Federal Coronavirus Loans (Marijuana Moment)

// Canada’s COVID-19 olive branch for cannabis sector comes with caveat (Marijuana Business Daily)

// FDA Declares Cannabis Drug Epidiolex No Longer A Controlled Substance (Green Market Report)


These headlines are brought to you by Curaleaf, one of the leading vertically-integrated cannabis operators in the U.S. With legal medical marijuana dispensaries, cultivation sites, and processing facilities all over the United States, Curaleaf has served more than 165,000 medical cannabis patients and looks forward to helping many more long into the future. Swing over to Curaleaf.com to learn more about this very cool company!


// Colorado eases hiring process for cannabis firms eyeing casino workers (Marijuana Business Daily)

// Delaware Officials Allow Medical Marijuana Delivery Amid Coronavirus Outbreak (Marijuana Moment)

// Phoenix marijuana dispensary hawks COVID-19 ‘immunization stabilizer,’ state orders it to stop (AZ Central)

// Illinois governor commutes sentence of jailed cancer patient (St. Louis Today (AP))

// 73% of Cannabis Consumers Get Lit to Relieve Anxiety During Coronavirus Pandemic (Merry Jane)

// iAnthus Capital Defaults On Debt, Investigates Claims Against CEO (Deep Dive)

// Two Marijuana Magazines Owned By High Times Suspend Publication Due To Coronavirus (Marijuana Moment)


Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: thefuturistics/Flickr

Tuesday, April 7, 2020 Headlines | Marijuana Today Daily News

Marijuana Today Daily Headlines
Tuesday, April 7, 2020 | Curated by host Shea Gunther

// Businesses That ‘Indirectly’ Work With Marijuana Industry Ineligible For Federal Coronavirus Loans (Marijuana Moment)

// Canada’s COVID-19 olive branch for cannabis sector comes with caveat (Marijuana Business Daily)

// FDA Declares Cannabis Drug Epidiolex No Longer A Controlled Substance (Green Market Report)


These headlines are brought to you by Curaleaf, one of the leading vertically-integrated cannabis operators in the U.S. With legal medical marijuana dispensaries, cultivation sites, and processing facilities all over the United States, Curaleaf has served more than 165,000 medical cannabis patients and looks forward to helping many more long into the future. Swing over to Curaleaf.com to learn more about this very cool company!


// Colorado eases hiring process for cannabis firms eyeing casino workers (Marijuana Business Daily)

// Delaware Officials Allow Medical Marijuana Delivery Amid Coronavirus Outbreak (Marijuana Moment)

// Phoenix marijuana dispensary hawks COVID-19 ‘immunization stabilizer,’ state orders it to stop (AZ Central)

// Illinois governor commutes sentence of jailed cancer patient (St. Louis Today (AP))

// 73% of Cannabis Consumers Get Lit to Relieve Anxiety During Coronavirus Pandemic (Merry Jane)

// iAnthus Capital Defaults On Debt, Investigates Claims Against CEO (Deep Dive)

// Two Marijuana Magazines Owned By High Times Suspend Publication Due To Coronavirus (Marijuana Moment)


Check out our other projects:Marijuana Today— Our flagship title, a weekly podcast examining the world of marijuana business and activism with some of the smartest people in the industry and movement. • Marijuana Media Connect— A service that connects industry insiders in the legal marijuana industry with journalists, bloggers, and writers in need of expert sources for their stories.

Love these headlines? Love our podcast? Support our work with a financial contribution and become a patron.

Photo: thefuturistics/Flickr